These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17634060)

  • 21. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself.
    Reddy DS; Rogawski MA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1241-8. PubMed ID: 11082461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsant doses of ganaxolone do not compromise motor performance in immature rats.
    Mares P; Stehlíková M
    Neurosci Lett; 2010 Jan; 469(3):396-9. PubMed ID: 20026384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SKATE study: interim analysis.
    Olwen GO
    Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies.
    Geoerger B; Doz F; Gentet JC; Mayer M; Landman-Parker J; Pichon F; Chastagner P; Rubie H; Frappaz D; Le Bouil A; Gupta S; Vassal G
    J Clin Oncol; 2008 Sep; 26(27):4394-400. PubMed ID: 18802151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and prognosis of a short course of prednisolone therapy for pediatric epilepsy.
    You SJ; Jung DE; Kim HD; Lee HS; Kang HC
    Eur J Paediatr Neurol; 2008 Jul; 12(4):314-20. PubMed ID: 17951084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review and meta-analysis on efficacy and safety of Ganaxolone in epilepsy.
    Khan P; Saini S; Hussain S; Majid H; Gupta S; Agarwal N
    Expert Opin Pharmacother; 2024 Apr; 25(5):621-632. PubMed ID: 38606458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discontinuation of anticonvulsant medication after epilepsy surgery in children.
    Hoppe C; Poepel A; Sassen R; Elger CE
    Epilepsia; 2006 Mar; 47(3):580-3. PubMed ID: 16529625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid dosage titration of levetiracetam in children.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lacosamide in pediatric and adult patients: comparison of efficacy and safety.
    Verrotti A; Loiacono G; Pizzolorusso A; Parisi P; Bruni O; Luchetti A; Zamponi N; Cappanera S; Grosso S; Kluger G; Janello C; Franzoni E; Elia M; Spalice A; Coppola G; Striano P; Pavone P; Savasta S; Viri M; Romeo A; Aloisi P; Gobbi G; Ferretti A; Cusmai R; Curatolo P
    Seizure; 2013 Apr; 22(3):210-6. PubMed ID: 23298605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rufinamide for refractory epilepsy in a pediatric and young adult population.
    Joseph JR; Schultz RJ; Wilfong AA
    Epilepsy Res; 2011 Jan; 93(1):87-9. PubMed ID: 21111576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy.
    Bergqvist AG; Schall JI; Gallagher PR; Cnaan A; Stallings VA
    Epilepsia; 2005 Nov; 46(11):1810-9. PubMed ID: 16302862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial.
    Togha M; Akhondzadeh S; Motamedi M; Ahmadi B; Razeghi S
    Arch Med Res; 2007 Apr; 38(3):313-6. PubMed ID: 17350481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
    Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
    Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.